Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Milan - Delayed Quote EUR

L&G Pharma Breakthrough UCITS ETF (BIOT.MI)

8.65
-0.01
(-0.10%)
As of April 17 at 3:37:58 PM GMT+2. Market Open.

Top 10 Holdings (29.78% of Total Assets)

SymbolCompany% Assets
XERS
Xeris Biopharma Holdings, Inc. 3.60%
ONC
BeiGene, Ltd. 3.11%
ALNY
Alnylam Pharmaceuticals, Inc. 3.07%
CPRX
Catalyst Pharmaceuticals, Inc. 3.07%
HALO
Halozyme Therapeutics, Inc. 2.91%
PHARM.AS
Pharming Group N.V. 2.84%
BMY
Bristol-Myers Squibb Company 2.82%
JNJ
Johnson & Johnson 2.81%
VRTX
Vertex Pharmaceuticals Incorporated 2.80%
BMRN
BioMarin Pharmaceutical Inc. 2.76%

Sector Weightings

SectorBIOT.MI
Healthcare   94.72%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Overall Portfolio Composition (%)

Stocks 99.93%
Bonds 0.00%

Equity Holdings

Price/Earnings 0.05
Price/Book 0.41
Price/Sales 0.41
Price/Cashflow 0.11
Median Market Cap --
3 Year Earnings Growth --

Bond Ratings

US Government 0.00%
AAA --
AA --
A --
BBB --
BB --
B --
Below B --
Other --

ETF Summary

null

ETF Overview

Category --
Fund Family LGIM Managers (Europe) Limited
Net Assets 20.39M
YTD Daily Total Return --
Yield --
Legal Type Exchange Traded Fund

Related Tickers